ADMA Biologics
ADMA
ADMA
34 hedge funds and large institutions have $78M invested in ADMA Biologics in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
52.84% less ownership
Funds ownership: 99% → 46.16% (-53%)
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.14M | |
| 2 | +$948K | |
| 3 | +$435K | |
| 4 |
Goldman Sachs
New York
|
+$289K |
| 5 |
JPMorgan Chase & Co
New York
|
+$182K |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$920K | |
| 3 | -$667K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$275K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$217K |